Sign Up Today and Learn More About PrognomiQ Stock
Invest in or calculate the value of your shares in PrognomiQ or other pre-IPO companies through EquityZen's platform.
PrognomiQ Stock (PROQ)
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
About PrognomiQ Stock
Founded
2020
Headquarters
San Mateo, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.
PrognomiQ Press Mentions
Stay in the know about the latest news on PrognomiQ
Methods of processing a biofluid sample
patents • Apr 02, 2025
Methods and systems for classifying pixelated raw mass spectrometry data
patents • Apr 02, 2025
Methods of identifying pancreatic cancer
patents • Apr 02, 2025
Multi-omics assessment
patents • Apr 02, 2025
Glycoprotein assessment
patents • Apr 02, 2025
PrognomiQ Management
Leadership team at PrognomiQ
Interim CFO
David Siewers
Chief Executive Officer, President & Founder
Philip Ma
Join now and verify your accreditation status to gain access to:
- PrognomiQ Current Valuation
- PrognomiQ Stock Price
- PrognomiQ Management
- Available deals in PrognomiQ and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PrognomiQ Cap Table and Funding History by Share Class and Liquidity Preferences
- PrognomiQ Revenue and Financials
- PrognomiQ Highlights
- PrognomiQ Business Model
- PrognomiQ Risk Factors
- PrognomiQ Research Report from SACRA Research
Trading PrognomiQ Stock
How to invest in PrognomiQ stock?
Accredited investors can buy pre-IPO stock in companies like PrognomiQ through EquityZen funds. These investments are made available by existing PrognomiQ shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PrognomiQ stock?
Shareholders can sell their PrognomiQ stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
